Ubs Group Ag Pds Biotechnology Corp Transaction History

Ubs Group Ag

$611 Billion
Q3 2025

A detailed history of Ubs Group Ag transactions in Pds Biotechnology Corp stock. As of the latest transaction made, Ubs Group Ag holds 200,236 shares of PDSB stock, worth $170,200. This represents 0.0% of its overall portfolio holdings.

Number of Shares

200,236

Previous 543,021 63.13%

Holding current value

$170,200

Previous $722,000 71.47%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	SELL	$1.01 - $1.33 $346,212 - $455,904	-342,785 Reduced 63.13%	200,236 $206,000
Q2 2025 Aug 14, 2025	BUY	$0.94 - $1.79 $274,353 - $522,438	291,865 Added 116.21%	543,021 $722,000
Q1 2025 May 13, 2025	BUY	$1.18 - $1.8 $237,295 - $361,976	201,098 Added 401.73%	251,156 $298,000
Q4 2024 Feb 14, 2025	BUY	$1.63 - $4.11 $48,613 - $122,576	29,824 Added 147.4%	50,058 $81,000
Q3 2024 Nov 14, 2024	SELL	$2.93 - $4.23 $116,479 - $168,159	-39,754 Reduced 66.27%	20,234 $77,000

Q2 2024 Aug 13, 2024	BUY	$2.55 - $4.02 $43,607 - $68,746	17,101 Added 39.87%	59,988 $175,000
Q1 2024 May 13, 2024	BUY	$3.85 - $6.59 $104,234 - $178,417	27,074 Added 171.21%	42,887 $169,000
Q4 2023 Feb 09, 2024	BUY	$3.95 - $6.58 $60,585 - $100,924	15,338 Added 3229.05%	15,813 $78,000
Q3 2023 Nov 09, 2023	SELL	$4.8 - $6.4 $33,720 - $44,960	-7,025 Reduced 93.67%	475 $2,000
Q2 2023 Aug 11, 2023	BUY	$5.03 - $9.9 $24,647 - $48,510	4,900 Added 188.46%	7,500 $37,000
Q1 2023 May 12, 2023	BUY	$5.68 - $11.99 $14,768 - $31,174	2,600 New	2,600 $15,000
Q3 2022 Nov 10, 2022	BUY	$2.97 - $5.79 $29,352 - $57,222	9,883 New	9,883 $30,000
Q2 2022 Aug 10, 2022	SELL	$3.05 - $6.68 $7,621 - $16,693	-2,499 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$4.78 - $8.43 $11,945 - $21,066	2,499 New	2,499 $15,000
Q4 2021 Feb 14, 2022	SELL	$7.76 - $14.35 $22,860 - $42,275	-2,946 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$9.33 - $17.08 $27,486 - $50,317	2,946 New	2,946 $44,000
Q1 2021 May 12, 2021	SELL	$2.28 - $6.81 $239,149 - $714,300	-104,890 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$1.91 - $2.67 $2,504 - $3,500	1,311 Added 1.27%	104,890 $224,000
Q3 2020 Nov 12, 2020	BUY	$1.67 - $4.67 $172,976 - $483,713	103,579 New	103,579 $241,000
Q2 2020 Jul 31, 2020	SELL	$0.65 - $2.6 $24,960 - $99,840	-38,400 Closed	0 $0
Q1 2020 May 01, 2020	BUY	$0.67 - $3.04 $22,076 - $100,168	32,950 Added 604.59%	38,400 $28,000
Q4 2019 Feb 14, 2020	BUY	$2.08 - $4.07 $11,336 - $22,181	5,450 New	5,450 $14,000
Q3 2019 Nov 14, 2019	SELL	$3.38 - $6.71 $5,350 - $10,621	-1,583 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$5.44 - $8.68 $8,611 - $13,740	1,583 New	1,583 $9,000

Others Institutions Holding PDSB

# of Institutions

Shares Held

5.62M

Call Options Held

247K

Put Options Held

View Full List

About PDS Biotechnology Corp

Ticker PDSB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,458,700
Market Cap $24.2M
Description
PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...

More about PDSB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account